Jasper Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2023-03-08
- Jasper Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $1.36M, a 34.33% decline from fiscal 2021.
- Jasper Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2021 was $2.07M.
- Jasper Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2020 was -$179.33K.
| Period end | Increase (Decrease) in Prepaid Expense 5 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|
| 2022-12-31 | $1.36M 10-K · filed 2023-03-08 | |
| 2021-12-31 | $2.07M 10-K · filed 2023-03-08 | |
| 2020-12-31 | -$179.33K 10-K/A · filed 2021-05-24 | |
| 2019-12-31 | $326.31K 10-K/A · filed 2021-05-24 |